AI assistant
Sending…
Riot Platforms, Inc. — Director's Dealing 2011
Jul 12, 2011
30793_dirs_2011-07-12_3a59ea30-3e91-492d-8919-ec9eaa243242.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AspenBio Pharma, Inc. (APPY)
CIK: 0001167419
Period of Report: 2011-07-08
Reporting Person: Lundy Steve (Director, CEO and President)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-07-08 | Stock Option (Right to Buy) | $0.68 | A | 400000 | Acquired | 2021-07-08 | Common Stock (400000) | Direct |
Footnotes
F1: The option to purchase 400,000 shares of common stock shall become exercisable as to 133,333 of the shares on each of July 8, 2012 and July 8, 2013, and as to the remaining 133,334 shares on July 8, 2014.
More from Riot Platforms, Inc.
Annual Report
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Mar 27
Annual Report
2026
Mar 2
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 13
Major Shareholding Notification
2026
Feb 5
Major Shareholding Notification
2026
Feb 4
Regulatory Filings
2026
Jan 16
Board/Management Information
2026
Jan 5